Buscar resultados de ensayos clínicos
Cutaneous T-cell Lymphoma - 27 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2008-08-29 Intervenciones: Drug: Enzastaurin 1125 mg loading dose then 500 mg, oral, daily, until disease progression |
Completed |
Nombre del estudio: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study Condición: Cutaneous T-Cell Lymphoma Fecha: 2008-10-22 Intervenciones: Drug: Tazarotene Topical 0.1 cream - apply to lesions on alternate days and at 2 week interval increase |
Recruiting |
Nombre del estudio: Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma Condición: Cutaneous T-cell Lymphoma Fecha: 2014-02-11 Intervenciones:
|
Withdrawn |
Nombre del estudio: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) Condición: Cutaneous T-cell Lymphoma (CTCL) Fecha: 2013-04-24 Intervenciones: Drug: Sirolimus 0.1% Ointment Sirolimus 0.1% ointment will be applied topically to all affected areas of |
Active, not recruiting |
Nombre del estudio: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) Condición: Cutaneous T Cell Lymphoma Fecha: 2012-07-15 Intervenciones:
|
Completed |
Nombre del estudio: Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2006-03-23 Intervenciones:
|
Completed |
Nombre del estudio: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) Condición: Cutaneous T-cell Lymphoma Fecha: 2005-03-24 Intervenciones: Drug: romidepsin (depsipeptide, FK228) Study patients received romidepsin at a dose of 14 mg/m^2 intrave |
Recruiting |
Nombre del estudio: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) Condición: Cutaneous T-Cell Lymphoma Fecha: 2015-10-29 Intervenciones: Biological: IPH4102 |
Recruiting |
Nombre del estudio: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) Condición: Cutaneous T Cell Lymphoma Fecha: 2015-09-06 Intervenciones: Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
Completed |
Nombre del estudio: Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) Condición: Refractory Cutaneous T-cell Lymphoma Fecha: 2009-11-03 Intervenciones:
|